AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 20092961 — intervention group
Group type: EXPERIMENTAL
Intervention: p53 expression
Number of subjects: 308
Study 20092961 — intervention group
Group type: EXPERIMENTAL
Intervention: MDM2 expression
Number of subjects: 308
Study 19127912 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture at 'cervical three points' combined with cake-separated moxibustion
Number of subjects: 91
Study 19127912 — intervention group
Group type: COMPARATOR
Intervention: Routine acupuncture at Jiaji (EX-B 2)
Number of subjects: 91
Study 17038305 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram
Number of subjects: 0
Study 17038305 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 14521760 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril (group A)
Number of subjects: 72
Study 14521760 — intervention group
Group type: COMPARATOR
Intervention: Routine treatment (group B)
Number of subjects: 72
Study 14521760 — intervention group
Group type: COMPARATOR
Intervention: Healthy volunteers (group C)
Number of subjects: 72
Study 11194611 — intervention group
Group type: EXPERIMENTAL
Intervention: Tissue expander implantation
Number of subjects: 0
Study 8864680 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 20mg once daily for 5 days
Number of subjects: 18
Study 8864680 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 40mg once daily for 5 days
Number of subjects: 18
Study 8864680 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 80mg once daily for 5 days
Number of subjects: 18
Study 1642520 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep diaphragmatic breathing training
Number of subjects: 67
Study 1642520 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 67
Study 1642520 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical exercise training
Number of subjects: 67
Study 6381337 — intervention group
Group type: EXPERIMENTAL
Intervention: human fibroblast interferon (beta 1-type)
Number of subjects: 10
Study 6381337 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 10
Study 31574029 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-Rich Plasma (PRP)
Number of subjects: 20
Study 31574029 — intervention group
Group type: COMPARATOR
Intervention: Topical Minoxidil
Number of subjects: 20
Study 30964365 — intervention group
Group type: EXPERIMENTAL
Intervention: Reslizumab add-on therapy
Number of subjects: 0
Study 30964365 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care alone (high-dose ICS/LABA)
Number of subjects: 0
Study 28776094 — intervention group
Group type: EXPERIMENTAL
Intervention: mindfulness based self-help programme (iMBI)
Number of subjects: 283
Study 28776094 — intervention group
Group type: EXPERIMENTAL
Intervention: music based self-help programme
Number of subjects: 283
Study 28776094 — intervention group
Group type: COMPARATOR
Intervention: waiting list control group
Number of subjects: 283
Study 26705327 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed electromagnetic fields (PEMF) therapy for 12 hours daily for 1 month
Number of subjects: 60
Study 26705327 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 24577972 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-month preventive intervention group
Number of subjects: 170
Study 24577972 — intervention group
Group type: COMPARATOR
Intervention: Standard care control group
Number of subjects: 170
Study 22658168 — intervention group
Group type: EXPERIMENTAL
Intervention: Nerve stimulation guided obturator nerve block with 15 mL of lidocaine HCl 2%
Number of subjects: 112
Study 22658168 — intervention group
Group type: EXPERIMENTAL
Intervention: Nerve stimulation guided obturator nerve block with 20 mL of saline
Number of subjects: 112
Study 22658168 — intervention group
Group type: COMPARATOR
Intervention: Blind obturator nerve block based on anatomic landmarks
Number of subjects: 112
Study 20304563 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenatal glucocorticoids and estrogen
Number of subjects: 0
Study 20304563 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregnancy
Number of subjects: 0
Study 17388849 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care plus cognitive nursing intervention (UC + CNI)
Number of subjects: 65
Study 17388849 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 65
Study 15766817 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipid-lowering therapy
Number of subjects: 10
Study 15766817 — intervention group
Group type: EXPERIMENTAL
Intervention: Shear stress (SS)
Number of subjects: 10
Study 15766817 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline WT
Number of subjects: 10
Study 16475175 — intervention group
Group type: EXPERIMENTAL
Intervention: Volumatic Soft (VS)
Number of subjects: 44
Study 16475175 — intervention group
Group type: COMPARATOR
Intervention: Volumatic (V)
Number of subjects: 44
Study 16475175 — intervention group
Group type: COMPARATOR
Intervention: Preference score for Volumatic (V)
Number of subjects: 44
Study 16475175 — intervention group
Group type: EXPERIMENTAL
Intervention: Preference score for Volumatic Soft (VS)
Number of subjects: 44
Study 10827335 — intervention group
Group type: EXPERIMENTAL
Intervention: Tactylon condoms
Number of subjects: 443
Study 10827335 — intervention group
Group type: COMPARATOR
Intervention: Latex condom
Number of subjects: 443
Study 8655825 — intervention group
Group type: EXPERIMENTAL
Intervention: Retropubic urethrocystopexy
Number of subjects: 45
Study 8655825 — intervention group
Group type: EXPERIMENTAL
Intervention: Pubococcygeal repair
Number of subjects: 45
Study 1519391 — intervention group
Group type: EXPERIMENTAL
Intervention: Mezlocillin/Metronidazole (group A)
Number of subjects: 111
Study 1519391 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin/Clavulanic acid (group B)
Number of subjects: 111
Study 6132449 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC)
Number of subjects: 0
Study 6132449 — intervention group
Group type: COMPARATOR
Intervention: Doxorubicin (DOX)
Number of subjects: 0
Study 29644545 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive parenting program (group sessions and one-to-one component including online videos and follow-up telephone calls)
Number of subjects: 15
Study 29644545 — intervention group
Group type: EXPERIMENTAL
Intervention: One-to-one component of the intervention
Number of subjects: 15
Study 29644545 — intervention group
Group type: EXPERIMENTAL
Intervention: Program modifications
Number of subjects: 15
Study 27494528 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-Based Cognitive Behavioral Therapy for Insomnia (VCBT-I)
Number of subjects: 80
Study 27062682 — intervention group
Group type: EXPERIMENTAL
Intervention: Worry Outcome Journal (WOJ)
Number of subjects: 51
Study 27062682 — intervention group
Group type: COMPARATOR
Intervention: Thought Log (TL)
Number of subjects: 51
Study 24629036 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher DCI (above the median)
Number of subjects: 1456
Study 24629036 — intervention group
Group type: COMPARATOR
Intervention: Lower DCI (below the median)
Number of subjects: 1456
Study 24629036 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean DCI
Number of subjects: 1456
Study 24629036 — intervention group
Group type: EXPERIMENTAL
Intervention: DCI
Number of subjects: 1456
Study 22146893 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipilimumab
Number of subjects: 45
Study 19664301 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 weeks refeeding
Number of subjects: 169
Study 19664301 — intervention group
Group type: COMPARATOR
Intervention: 1 week refeeding
Number of subjects: 169
Study 19664301 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 169
Study 18050245 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram (10‐20 mg/day)
Number of subjects: 392
Study 18050245 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine XR (75‐225 mg/day)
Number of subjects: 392
Study 18050245 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 392
Study 16351798 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoledronic acid
Number of subjects: 216
Study 16351798 — intervention group
Group type: COMPARATOR
Intervention: Pamidronate
Number of subjects: 216
Study 11796272 — intervention group
Group type: EXPERIMENTAL
Intervention: 7F tail stent with an 18F Councill nephrostomy tube (group B, n = 20)
Number of subjects: 40
Study 11796272 — intervention group
Group type: COMPARATOR
Intervention: 24F re‐entry Malecot nephrostomy tube (group A, n = 20)
Number of subjects: 40
Study 10190769 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen (2400 mg x d(‐1))
Number of subjects: 10
Study 10190769 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 7671564 — intervention group
Group type: EXPERIMENTAL
Intervention: Mannitol infusion
Number of subjects: 6
Study 7671564 — intervention group
Group type: EXPERIMENTAL
Intervention: Arginine vasopressin infusion (0.5 m-units/min)
Number of subjects: 6
Study 7671564 — intervention group
Group type: EXPERIMENTAL
Intervention: Arginine vasopressin superimposed on mannitol infusion
Number of subjects: 6
Study 29619793 — intervention group
Group type: EXPERIMENTAL
Intervention: FIFA 11+ (N=10)
Number of subjects: 21
Study 29619793 — intervention group
Group type: COMPARATOR
Intervention: Conventional dynamic WU exercise (Control, N=11)
Number of subjects: 21
Study 29619793 — intervention group
Group type: EXPERIMENTAL
Intervention: FIFA 11+ and Conventional dynamic WU exercises
Number of subjects: 21
Study 30894898 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise training (3 sessions per week, 45 minutes each, for 8 weeks)
Number of subjects: 80
Study 30894898 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise intervention)
Number of subjects: 80
Study 27417920 — intervention group
Group type: EXPERIMENTAL
Intervention: Diverted patients
Number of subjects: 100
Study 27417920 — intervention group
Group type: COMPARATOR
Intervention: Control group (40 normal male volunteers)
Number of subjects: 100
Study 24690084 — intervention group
Group type: EXPERIMENTAL
Intervention: Miller blade
Number of subjects: 120
Study 24690084 — intervention group
Group type: EXPERIMENTAL
Intervention: Macintosh blade
Number of subjects: 120
Study 24690084 — intervention group
Group type: COMPARATOR
Intervention: Both blades
Number of subjects: 120
Study 21549557 — intervention group
Group type: EXPERIMENTAL
Intervention: Uncemented fully porous‐coated composite stem (Epoch; Zimmer)
Number of subjects: 38
Study 21549557 — intervention group
Group type: COMPARATOR
Intervention: Uncemented proximally porous‐coated solid stem (Anatomic; Zimmer)
Number of subjects: 38
Study 19647525 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute sleep deprivation
Number of subjects: 102
Study 19647525 — intervention group
Group type: COMPARATOR
Intervention: No sleep deprivation (control)
Number of subjects: 102
Study 18092435 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraumbilical vein oxytocin (10 units diluted with 10 ml of normal saline)
Number of subjects: 100
Study 18092435 — intervention group
Group type: COMPARATOR
Intervention: Intravenous infusion of oxytocin (10 units in 500 ml of normal saline)
Number of subjects: 100
Study 15207988 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity from 1982 to 1995
Number of subjects: 171
Study 15207988 — intervention group
Group type: COMPARATOR
Intervention: Obesity from 1982 to 1995
Number of subjects: 171
Study 11443192 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsatile iv GnRH administration (0.1 microg/kg every 90 min)
Number of subjects: 15
Study 11443192 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 9532329 — intervention group
Group type: EXPERIMENTAL
Intervention: Meropenem administered as intravenous infusions at a dose of 1 g every 8 hours for 4 to 41 days (median of 11 days)
Number of subjects: 11
Study 8033141 — intervention group
Group type: EXPERIMENTAL
Intervention: M‐CSF at 100 micrograms/kg/day and gamma‐IFN at 0.1 mg/m2/day
Number of subjects: 36
Study 8033141 — intervention group
Group type: EXPERIMENTAL
Intervention: M‐CSF at 140 micrograms/kg/day
Number of subjects: 36
Study 8033141 — intervention group
Group type: EXPERIMENTAL
Intervention: M‐CSF at 100 micrograms/kg/day
Number of subjects: 36
Study 8033141 — intervention group
Group type: COMPARATOR
Intervention: M‐CSF therapy alone at the same dose
Number of subjects: 36
Study 8033141 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy with M‐CSF and gamma‐IFN
Number of subjects: 36
Study 8033141 — intervention group
Group type: EXPERIMENTAL
Intervention: M‐CSF and gamma‐IFN therapy
Number of subjects: 36
Study 2721018 — intervention group
Group type: EXPERIMENTAL
Intervention: Local anaesthesia
Number of subjects: 38
Study 2721018 — intervention group
Group type: COMPARATOR
Intervention: General anaesthesia
Number of subjects: 38
Study 1132079 — intervention group
Group type: EXPERIMENTAL
Intervention: High sodium intake (410 mEq/24hr)
Number of subjects: 6
Study 1132079 — intervention group
Group type: COMPARATOR
Intervention: Low sodium intake (10 mEq/24hr)
Number of subjects: 6
Study 29933355 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (800 mg)
Number of subjects: 15
Study 31254137 — intervention group
Group type: EXPERIMENTAL
Intervention: Very early analgesia (VEA) group
Number of subjects: 306
Study 31254137 — intervention group
Group type: COMPARATOR
Intervention: Postoperative analgesia (PA) group
Number of subjects: 306
Study 27610609 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin-clavulanate 875 mg/125 mg twice daily (BID) for 14 days
Number of subjects: 32
Study 27610609 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsules for 14 days
Number of subjects: 32
Study 25887964 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-month WIC enhanced plus internet-based weight loss intervention
Number of subjects: 408
Study 25887964 — intervention group
Group type: COMPARATOR
Intervention: 12-month standard WIC intervention
Number of subjects: 408
Study 23216297 — intervention group
Group type: EXPERIMENTAL
Intervention: Body empowerment intervention (5 weekly sessions)
Number of subjects: 198
Study 23216297 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=99)
Number of subjects: 198
Study 21524316 — intervention group
Group type: EXPERIMENTAL
Intervention: PRECEDE model
Number of subjects: 600
Study 21524316 — intervention group
Group type: COMPARATOR
Intervention: Conventional model
Number of subjects: 600
Study 17868402 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical sphincterotomy (SS)
Number of subjects: 279
Study 17868402 — intervention group
Group type: COMPARATOR
Intervention: Chemical sphincterotomy (CS)
Number of subjects: 279
Study 16573163 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrin and FAK antibody blocking
Number of subjects: 10
Study 16573163 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 10
Study 12710758 — intervention group
Group type: EXPERIMENTAL
Intervention: 25% metronidazole gel
Number of subjects: 20
Study 12710758 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 20
Study 11063284 — intervention group
Group type: EXPERIMENTAL
Intervention: Strong beliefs in shared autonomy
Number of subjects: 36
Study 11063284 — intervention group
Group type: EXPERIMENTAL
Intervention: Strong beliefs in independent autonomy
Number of subjects: 36
Study 11063284 — intervention group
Group type: EXPERIMENTAL
Intervention: Strong beliefs in paternalism
Number of subjects: 36
Study 11063284 — intervention group
Group type: EXPERIMENTAL
Intervention: Communication behaviors during decision making
Number of subjects: 36
Study 9206079 — intervention group
Group type: EXPERIMENTAL
Intervention: Activity sensing rate adaptive ventricular pacing (VVIR)
Number of subjects: 19
Study 9206079 — intervention group
Group type: COMPARATOR
Intervention: Fixed rate ventricular pacing (VVI)
Number of subjects: 19
Study 1598954 — intervention group
Group type: EXPERIMENTAL
Intervention: norfloxacin ophthalmic solution 0.3%
Number of subjects: 488
Study 1598954 — intervention group
Group type: COMPARATOR
Intervention: gentamicin ophthalmic solution 0.3%
Number of subjects: 488
Study 6420445 — intervention group
Group type: EXPERIMENTAL
Intervention: naloxone (22 micrograms/min)
Number of subjects: 16
Study 6420445 — intervention group
Group type: COMPARATOR
Intervention: saline (control)
Number of subjects: 16
Study 29606109 — intervention group
Group type: EXPERIMENTAL
Intervention: Apalutamide + degarelix
Number of subjects: 84
Study 29606109 — intervention group
Group type: COMPARATOR
Intervention: Placebo + degarelix
Number of subjects: 84
Study 25882391 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 225
Study 25882391 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone plus parent training
Number of subjects: 225
Study 25882391 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 225
Study 24191305 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual therapy (ramipril and telmisartan)
Number of subjects: 0
Study 24191305 — intervention group
Group type: COMPARATOR
Intervention: Monotherapy (ramipril or telmisartan)
Number of subjects: 0
Study 24191305 — intervention group
Group type: EXPERIMENTAL
Intervention: Both dual therapy and monotherapy
Number of subjects: 0
Study 22301410 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-2 therapy (6 million units, twice daily for 5 days at weeks 0, 8, and 16)
Number of subjects: 148
Study 22301410 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-2 therapy
Number of subjects: 148
Study 22301410 — intervention group
Group type: COMPARATOR
Intervention: Control (ART alone)
Number of subjects: 148
Study 20618582 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication and medication referral as a treatment option
Number of subjects: 322
Study 20618582 — intervention group
Group type: EXPERIMENTAL
Intervention: Dedicated university class in psychopharmacology
Number of subjects: 322
Study 20618582 — intervention group
Group type: EXPERIMENTAL
Intervention: Training in psychotropic medications
Number of subjects: 322
Study 20618582 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnostic practices
Number of subjects: 322
Study 18982034 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mL of 10% sodium fluorescein
Number of subjects: 1200
Study 18982034 — intervention group
Group type: COMPARATOR
Intervention: 5 mL of 10% sodium fluorescein
Number of subjects: 1200
Study 15186298 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation training administered by school nurses
Number of subjects: 63
Study 15186298 — intervention group
Group type: COMPARATOR
Intervention: Control group (untreated subjects)
Number of subjects: 63
Study 12167794 — intervention group
Group type: EXPERIMENTAL
Intervention: Mosaic bioprosthesis (Medtronic, Inc, Minneapolis, Minn)
Number of subjects: 561
Study 9704736 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alpha‐2b (IFN) maintenance therapy (2 mU/m2 subcutaneously three times per week)
Number of subjects: 0
Study 9704736 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 8583467 — intervention group
Group type: EXPERIMENTAL
Intervention: Random zero sphygmomanometer
Number of subjects: 62
Study 8583467 — intervention group
Group type: COMPARATOR
Intervention: Automatic oscillometric BP monitor
Number of subjects: 62
Study 2566293 — intervention group
Group type: EXPERIMENTAL
Intervention: Thymomodulin (80 mg daily orally)
Number of subjects: 16
Study 2566293 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 28990 — intervention group
Group type: EXPERIMENTAL
Intervention: Triazolam 0.5 mg
Number of subjects: 76
Study 28990 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study 28990 — intervention group
Group type: COMPARATOR
Intervention: Secobarbital 100 mg
Number of subjects: 76
Study 30427741 — intervention group
Group type: EXPERIMENTAL
Intervention: V180 formulations with ISCOMATRIX™ adjuvant
Number of subjects: 98
Study 30427741 — intervention group
Group type: EXPERIMENTAL
Intervention: Aluminum-adjuvanted formulations
Number of subjects: 98
Study 30427741 — intervention group
Group type: EXPERIMENTAL
Intervention: Unadjuvanted formulations
Number of subjects: 98
Study 30427741 — intervention group
Group type: EXPERIMENTAL
Intervention: All 9 V180 formulations
Number of subjects: 98
Study 30427741 — intervention group
Group type: EXPERIMENTAL
Intervention: Formulations with ISCOMATRIX™ adjuvant
Number of subjects: 98
Study 30427741 — intervention group
Group type: COMPARATOR
Intervention: Phosphate-buffered saline placebo
Number of subjects: 98
Study 29369527 — intervention group
Group type: EXPERIMENTAL
Intervention: Preservative-free dexamethasone (DEX)
Number of subjects: 180
Study 29369527 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac (DICL)
Number of subjects: 180
Study 29369527 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of DEX and DICL
Number of subjects: 180
Study 27055444 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term interdisciplinary treatment (LG) - 10 sessions of cognitive behavioral therapy (CBT) and exercise training for 10 weeks.
Number of subjects: 66
Study 27055444 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term interdisciplinary treatment (SG) - 2 full days of educational, exercise, and CBT programs.
Number of subjects: 66
Study 27055444 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) - no intervention reported.
Number of subjects: 66
Study 24739759 — intervention group
Group type: EXPERIMENTAL
Intervention: CDX-1401 vaccine with TLR agonists (resiquimod and Hiltonol)
Number of subjects: 45
Study 24739759 — intervention group
Group type: EXPERIMENTAL
Intervention: CDX-1401 vaccine
Number of subjects: 45
Study 24739759 — intervention group
Group type: EXPERIMENTAL
Intervention: CDX-1401 vaccine followed by immune-checkpoint inhibitors
Number of subjects: 45
Study 23725789 — intervention group
Group type: EXPERIMENTAL
Intervention: FeFA with or without Zn
Number of subjects: 247
Study 23725789 — intervention group
Group type: EXPERIMENTAL
Intervention: FeFA alone
Number of subjects: 247
Study 23725789 — intervention group
Group type: EXPERIMENTAL
Intervention: Zn alone
Number of subjects: 247
Study 23725789 — intervention group
Group type: EXPERIMENTAL
Intervention: Malaria incidence
Number of subjects: 247
Study 20802899 — intervention group
Group type: EXPERIMENTAL
Intervention: Phacoemulsification (PHACO)
Number of subjects: 205
Study 20802899 — intervention group
Group type: COMPARATOR
Intervention: Extracapsular extraction (ECCE)
Number of subjects: 205
Study 19065903 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin 100 mg per day + NXT 9 tablets per day
Number of subjects: 145